Wnt1 is epistatic to Id2 in inducing mammary hyperplasia, ductal side-branching, and tumors in the mouse

BMC Cancer

Volumn 4, Issue , 2004, Pages

  Marino, Susan ^a   Romelfanger, Claire ^a   Yokota, Yoshifumi ^b   Nusse, Roel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF DIFFERENTIATION 2; WNT1 PROTEIN; DNA BINDING PROTEIN; IDB2 PROTEIN, MOUSE; REPRESSOR PROTEIN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR; WNT PROTEIN; WNT1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; BREAST HYPERPLASIA; BREAST TUMOR; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; MALE; MAMMARY GLAND; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; ANIMAL; EXPERIMENTAL NEOPLASM; GENE EXPRESSION; GENETIC EPISTASIS; GENETICS; HYPERPLASIA; PATHOLOGY; PREGNANCY; TRANSGENIC MOUSE; UDDER;

ANIMALS; DNA-BINDING PROTEINS; EPISTASIS, GENETIC; FEMALE; GENE EXPRESSION; HYPERPLASIA; INHIBITOR OF DIFFERENTIATION PROTEIN 2; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, TRANSGENIC; PREGNANCY; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; WNT PROTEINS; WNT1 PROTEIN;

EID: 13144288186     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-4-91     Document Type: Article

References (12)

1. Grandori C, Cowley SM, James LP, Eisenman RN: The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000, 16:653-699.
2. Norton JD, Deed RW, Craggs G, Sablitzky F: Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol 1998, 8:58-65.
3. Yokota Y, Mori S, Nishikawa SI, Mansouri A, Gruss P, Kusunoki T, Katakai T, Shimizu A: The helix-loop-helix inhibitor Id2 and cell differentiation control. Curr Top Microbiol Immunol 2000, 251:35-41.
4. Mori S, Nishikawa SI, Yokota Y: Lactation defect in mice lacking the helix-loop-helix inhibitor Id2. EMBO J 2000, 19: 772-5781.
5. Willert J, Epping M, Pollack JR, Brown PO, Nusse R: A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2002, 2:8.
6. Rockman SP, Currie SA, Ciavarella M, Vincan E, Dow C, Thomas RJ, Phillips WA: Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. J Biol Chem 2001, 276: 5113-45119.
7. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE: Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988, 55:619-625.
8. Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, Nishikawa S, Gruss P: Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 1999, 397:702-706.
9. Tetsu O, McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398: 22-426.
10. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994, 369:669-671.
11. Yu Q, Geng Y, Sicinski P: Specific protection against breast cancers by cyclin D1 ablation. Nature 2001, 411: 017-1021.
12. Mori S, Inoshima K, Shima Y, Schmidt EV, Yokota Y: Forced expression of cyclin D1 does not compensate for Id2 deficiency in the mammary gland. FEBS Lett 2003, 551:123-127.